BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Nanotherapeutics Celebrates Groundbreaking of its Advanced Development and Manufacturing Center (NANO-ADM) in Copeland Park, Alachua, FL


10/23/2013 11:51:04 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

ALACHUA, Fla.--(BUSINESS WIRE)--Nanotherapeutics, Inc. today announced that a groundbreaking ceremony for its Advanced Development and Manufacturing Center (NANO-ADM) in Copeland Park, Alachua, FL, will be held this morning at 9:00am ET. The event will be hosted by Tim Giuliani, President of the Gainesville Area Chamber of Commerce. Featured speakers will include Governor Rick Scott, The Honorable Gib Coerper, Mayor of the City of Alachua, and James Talton, Ph.D., Co-founder, President and Chief Executive Officer of Nanotherapeutics. The ceremony celebrates the groundbreaking of the 30-acre NANO-ADM Center, being constructed through privately secured financing to fulfill the contract awarded to Nanotherapeutics by the U.S. Department of Defense (DOD) earlier this year. Nanotherapeutics, as the prime contractor for the contract, is responsible for ensuring that all the core services necessary to establish a Medical Countermeasures Advanced Development and Manufacturing (MCM ADM) capability are provided to the DOD. The goal of the contract is to enable faster and more effective development of medical countermeasures designed to protect and treat military populations against chemical, biological, radiological and nuclear attacks and outbreaks of naturally occurring, emerging and genetically engineered infectious diseases.

Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES